Skip to main content

Table 1 Hepatic MDA, GSH levels, GR, GPx and SOD activities in different experimental groups

From: The chemopreventive effect of Ginkgo biloba and Silybum marianum extracts on hepatocarcinogenesis in rats

Groups MDA
(nmol MDA/g tissue)
GSH
(mg/g tissue)
GR
(nmol NADPH reacted/min/mg protein)
GPx
(nmol NADPH reacted/min/mg protein)
SOD
(nmol NADPH reacted/min/mg protein)
Control 11.65 ± 1.10 6.86 ± 1.21 85.94 ± 5.74 102.26 ± 8.43 49.34 ± 3.08
NDEA 22.97 ± 2.79 a 0.43 ± 0.10 a 51.94 ± 2.88 a 18.34 ± 3.49 a 5.28 ± 0.82 a
Pre S.m 13.89 ± 1.89 b 3.38 ± 0.16 b 72.44 ± 3.91 b 25.26 ± 2.76 b 37.04 ± 4.76 b
Pre G.b 14.42 ± 1.56 b 4.54 ± 1.00 b 77.27 ± 13.15 b 36.63 ± 4.10 b 32.28 ± 3.23 b
Post S.m 16.74 ± 2.90 b,c 2.36 ± 0.45 b,c 62.51 ± 5.50 b,c 20.00 ± 1.67 c 17.39 ± 2.40 b,c
Post G.b 17.53 ± 3.32 b,d 3.64 ± 0.57 b,d 61.47 ± 6.42 b,d 29.84 ± 2.92 b,d 20.92 ± 1.77 b,d
  1. Results are given as mean ± S.D. for 6 rats. Pre S.m= Pretreated silymarin, Pre G.b= Pretreated EGb, Post S.m= Posttreated silymarin, Post G.b= Posttreated EGb. a: significantly different from control group at p ≤ 0.05. b: significantly different from NDEA group at p ≤ 0.05. c: significantly different from Pre S.m group at p ≤ 0.05. d: significantly different from Pre G.b group at p ≤ 0.05.